HMS Holdings Corp secures stake in MedAdvisor

By Naomi Neilson|22 October 2019
Baker McKenzie

Baker McKenzie has assisted HMS Holdings Corp in securing a stake in MedAdvisor.

Firm: Baker McKenzie (HMS Holdings Corp)

Advertisement
Advertisement

Deal: Baker McKenzie has acted for Nasdaq-listed HMS Holdings Corp on its 13 per cent stake investment in the ASX-listed MedAdvisor.

Value: Undisclosed.

SPONSORED CONTENT

Area: Investments.

Key players: The team was led by head of M&A Richard Lustig, who was assisted by Xavier Keary and Ben McLaughlin.

Deal significance: MedAdvisor offers a software platform to make the management of medication easier. MedAdvisor connects to a patient’s pharmacy to provide them with details of the patient’s medication and prescriptions to make the process effective.

According to HMS Holdings Corp, the investment marks the launch of its strategic partnership with MedAdvisor to tackle the global issues of medication non-adherence.

Mr Lustig said: “The future of healthcare delivery is rapidly evolving to better meet the needs of patients given new technologies underpinned by constant innovation. We were delighted to assist HMS Holdings Corp on this cross-border deal which will meet the strategic needs of their business.”

This email address is being protected from spambots. You need JavaScript enabled to view it.

HMS Holdings Corp secures stake in MedAdvisor
Intro image
lawyersweekly logo
Big Law

latest

Do lawyers want to go back to the office

Do lawyers want to go back to the office?

Top 10 post-COVID predictions for law

Top 10 post-COVID predictions for law

Rachel Setti

Productivity must be audited and redefined post-pandemic

Natalie Stoll

Answering the call of duty during COVID-19

FROM THE WEB
Recommended by Spike Native Network